ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 759630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 759630; 2) Community: the network communities that were significantly associated with the response to NSC 759630; 3) Molecule: the relationships between components within communities and NSC 759630; 4) MDR: the compounds that were significantly associated with the NSC 759630.

NSC Compound Enrichment Correlation
NSC 737606 Null 0.0438391811600409 0.12143425
NSC 749160 Null 0.0438391811600409 0.23357089
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.045446901295916 -0.33412229
NSC 9358 2-[[p-(dimethylamino)phenyl]azo]pyridine 0.045446901295916 0.11026613
NSC 93739 Aizen Magenta 0.045446901295916 0.19911387
NSC 114382 Null 0.0454469012959173 0.16087348
NSC 116878 Cardiac glycoside 0.0454469012959173 0.57772573
NSC 135371 Null 0.0454469012959173 0.26822611
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.0454469012959173 0.45074616
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0454469012959173 0.15500041
Total:54  Current:44    [First] [Prev] [Next] [Last]